Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial

Norwegian RCT (n=399) found pharmacist-led medicines management had no significant effect on time to readmission or death within 12 months, however a statistically significantly increased overall survival was observed during 21–40 months follow-up (HR 0.66, 95%CI 0.48-0.90).

Source:

BMJ Open